Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Lixte Biotechnology Holdings, Inc. (LIXT.OB)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lixte Biotechnology Holdings, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Lixte Biotechnology Holdings, Inc. since 2005.
The reporting company's ticker symbol is LIXT.OB. The reporting company's CIK number is 1335105.
The total value of stock buying since 2005 is $1,325,915.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-07||Forman Stephen J. (Director)||Buy||100,000||.50||50,000|
|2018-12-07||Riggs Jane Merrill (10% Owner)||Buy||1,260,000||.50||630,000|
|2018-12-07||Schwartzberg Gil (10% Owner)||Buy||1,040,000||.50||520,000|
|2018-12-07||Palmedo Philip F (Director)||Buy||100,000||.50||50,000|
Insider trading activities including stock purchases, stock sales, and option exercises of LIXT.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lixte Biotechnology Holdings, Inc. (symbol LIXT.OB, CIK number 1335105) see the Securities and Exchange Commission (SEC) website.